134 related articles for article (PubMed ID: 33215489)
21. Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study.
Paulone S; Malavasi G; Ardizzoni A; Orsi CF; Peppoloni S; Neglia RG; Blasi E
New Microbiol; 2017 Jan; 40(1):45-52. PubMed ID: 28217816
[TBL] [Abstract][Full Text] [Related]
22. Interaction between chlorhexidine and fluoride in a mouthrinse solution-a 4-day and 6-week randomized clinical pilot study.
Villa O; Ramberg P; Fukui H; Emilson CG; Papanikolaou G; Heijl L; Birkhed D
Clin Oral Investig; 2018 Apr; 22(3):1439-1448. PubMed ID: 29032402
[TBL] [Abstract][Full Text] [Related]
23. In vitro effect of chlorhexidine mouth rinses on polyspecies biofilms.
Guggenheim B; Meier A
Schweiz Monatsschr Zahnmed; 2011; 121(5):432-41. PubMed ID: 21656386
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticle-encapsulated chlorhexidine against oral bacterial biofilms.
Seneviratne CJ; Leung KC; Wong CH; Lee SF; Li X; Leung PC; Lau CB; Wat E; Jin L
PLoS One; 2014; 9(8):e103234. PubMed ID: 25170958
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic antimicrobial effect of safranine O on an ex vivo periodontal biofilm.
Voos AC; Kranz S; Tonndorf-Martini S; Voelpel A; Sigusch H; Staudte H; Albrecht V; Sigusch BW
Lasers Surg Med; 2014 Mar; 46(3):235-43. PubMed ID: 24473989
[TBL] [Abstract][Full Text] [Related]
26.
Collins JR; Olsen J; Cuesta A; Silva-Vetri M; Hernández M; Romanos G; Rajendra Santosh AB; Palma P
Indian J Dent Res; 2018; 29(6):799-807. PubMed ID: 30589011
[TBL] [Abstract][Full Text] [Related]
27. The antifungal properties of chlorhexidine digluconate and cetylpyrinidinium chloride on oral Candida.
Fathilah AR; Himratul-Aznita WH; Fatheen AR; Suriani KR
J Dent; 2012 Jul; 40(7):609-15. PubMed ID: 22521700
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of ozone against periodontal pathogenic microorganisms.
Huth KC; Quirling M; Lenzke S; Paschos E; Kamereck K; Brand K; Hickel R; Ilie N
Eur J Oral Sci; 2011 Jun; 119(3):204-10. PubMed ID: 21564314
[TBL] [Abstract][Full Text] [Related]
29. [Assessment of antimicrobial activity of bioflavonoid CITROX and chlorhexidine combination against P. gingivalis (in vitro)].
Baykulova SB
Stomatologiia (Mosk); 2022; 101(2):14-18. PubMed ID: 35362697
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial and physicochemical characterization of endodontic sealers after exposure to chlorhexidine digluconate.
Kapralos V; Rukke HV; Ørstavik D; Koutroulis A; Camilleri J; Sunde PT
Dent Mater; 2021 Feb; 37(2):249-263. PubMed ID: 33293036
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Assessment of Antifungal and Antibiofilm Efficacy of Commercial Mouthwashes against
Korbecka-Paczkowska M; Karpiński TM
Antibiotics (Basel); 2024 Jan; 13(2):. PubMed ID: 38391503
[No Abstract] [Full Text] [Related]
32. Effect of modified nonequilibrium plasma with chlorhexidine digluconate against endodontic biofilms in vitro.
Du T; Shi Q; Shen Y; Cao Y; Ma J; Lu X; Xiong Z; Haapasalo M
J Endod; 2013 Nov; 39(11):1438-43. PubMed ID: 24139270
[TBL] [Abstract][Full Text] [Related]
33. Effect of pH-sensitive nanoparticles on inhibiting oral biofilms.
Peng X; Han Q; Zhou X; Chen Y; Huang X; Guo X; Peng R; Wang H; Peng X; Cheng L
Drug Deliv; 2022 Dec; 29(1):561-573. PubMed ID: 35156501
[TBL] [Abstract][Full Text] [Related]
34. Effect of xylitol/chlorhexidine versus xylitol or chlorhexidine as single rinses on initial biofilm formation of cariogenic streptococci.
Decker EM; Maier G; Axmann D; Brecx M; von Ohle C
Quintessence Int; 2008 Jan; 39(1):17-22. PubMed ID: 18551212
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial effectiveness of an herbal mouthrinse compared with an essential oil and a chlorhexidine mouthrinse.
Haffajee AD; Yaskell T; Socransky SS
J Am Dent Assoc; 2008 May; 139(5):606-11. PubMed ID: 18451378
[TBL] [Abstract][Full Text] [Related]
36. [The bactericidal activity of mouthwashes containing 0.10%, 0.12% and 0.20% chlorhexidine digluconate].
Luc J; Mroz C; Roques C; Ducani-Federlin M
Bull Group Int Rech Sci Stomatol Odontol; 1998; 40(2-3):102-8. PubMed ID: 9861770
[TBL] [Abstract][Full Text] [Related]
37. Investigating the biological properties of carbohydrate derived fulvic acid (CHD-FA) as a potential novel therapy for the management of oral biofilm infections.
Sherry L; Millhouse E; Lappin DF; Murray C; Culshaw S; Nile CJ; Ramage G
BMC Oral Health; 2013 Sep; 13():47. PubMed ID: 24063298
[TBL] [Abstract][Full Text] [Related]
38. Development of an in vitro periodontal biofilm model for assessing antimicrobial and host modulatory effects of bioactive molecules.
Millhouse E; Jose A; Sherry L; Lappin DF; Patel N; Middleton AM; Pratten J; Culshaw S; Ramage G
BMC Oral Health; 2014 Jun; 14():80. PubMed ID: 24972711
[TBL] [Abstract][Full Text] [Related]
39. Killing activity of LFchimera on periodontopathic bacteria and multispecies oral biofilm formation in vitro.
Ruangcharoen S; Suwannarong W; Lachica MRCT; Bolscher JGM; Nazmi K; Khunkitti W; Taweechaisupapong S
World J Microbiol Biotechnol; 2017 Aug; 33(9):167. PubMed ID: 28823045
[TBL] [Abstract][Full Text] [Related]
40. Recovery of Oral In Vitro Biofilms after Exposure to Peptides and Chlorhexidine.
Zhang T; Xia L; Wang Z; Hancock REW; Haapasalo M
J Endod; 2021 Mar; 47(3):466-471. PubMed ID: 33248060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
